CMS dementia care pilot program to expand care delivery options
By
Kimberly Bonvissuto
Aug 01, 2023
Assisted living residents may be part of a new Medicare dementia care model that will test an alternative payment for family caregivers while expanding care delivery options to allow people living with...
More news for Friday, May 5
By
Kimberly Bonvissuto
May 05, 2023
Season of Reflection is 2023 theme for National Assisted Living Week … Most older adults say they will get updated COVID-19 booster, but will they? … First-ever RSV vaccine gets FDA nod, approved for...
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
43 recommendations help fill gap in medical and mental healthcare guidance for assisted living, experts...
By
Lois A. Bowers
Oct 03, 2022
Forty-three recommendations from a new study will guide medical and mental healthcare in assisted living, the authors say.
More news for Friday, Sept. 30
By
Kimberly Bonvissuto
Sep 30, 2022
LeadingAge provides feedback on HUD’s proposed changes to affordable housing contracts … Daily activity, HDL cholesterol inform new life expectancy model … NCAL endorses Expanding Service Coordinators...
Feds’ antipsychotic drug reduction efforts in assisted living fail to produce success seen in nursing...
By
Alicia Lasek
Aug 23, 2022
A federal initiative to reduce antipsychotic prescribing in long-term care facilities failed to impact prescriptions in assisted living residents with dementia, the first study of its kind has found.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
15 percent of off-label antipsychotic use in assisted living may be inappropriate, but nursing home reduction...
By
Kimberly Bonvissuto
Sep 14, 2021
The rate of potentially inappropriate prescribing of drugs in assisted living is 15% for antipsychotics and 21% for antianxiety medications, according to the authors of a new study published in JAMDA,...
‘Gold standard’ for dementia care focuses on person-centered practices: panel
By
Kimberly Bonvissuto
Jun 17, 2021
Designing a quality memory care program for people living with dementia is more than an activity calendar and a locked hallway, according to speakers during Wednesday’s Pioneer Network virtual symposium,...